journal
https://read.qxmd.com/read/38455373/manufacturing-car-nk-against-tumors-who-is-the-ideal-supplier
#1
JOURNAL ARTICLE
Feifei Guo, Yi Zhang, Jiuwei Cui
Chimeric antigen receptor-natural killer (CAR-NK) cells have emerged as another prominent player in the realm of tumor immunotherapy following CAR-T cells. The unique features of CAR-NK cells make it possible to compensate for deficiencies in CAR-T therapy, such as the complexity of the manufacturing process, clinical adverse events, and solid tumor challenges. To date, CAR-NK products from different allogeneic sources have exhibited remarkable anti-tumor effects on preclinical studies and have gradually been applied in clinical practice...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455372/risk-stratification-for-radioactive-iodine-refractoriness-using-molecular-alterations-in-distant-metastatic-differentiated-thyroid-cancer
#2
JOURNAL ARTICLE
Zhuanzhuan Mu, Xin Zhang, Dongquan Liang, Jugao Fang, Ge Chen, Wenting Guo, Di Sun, Yuqing Sun, Zhentian Kai, Lisha Huang, Jun Liang, Yansong Lin
OBJECTIVE: Patients with radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) are often diagnosed with delay and constrained to limited treatment options. The correlation between RAI refractoriness and the underlying genetic characteristics has not been extensively studied. METHODS: Adult patients with distant metastatic DTC were enrolled and assigned to undergo next-generation sequencing of a customized 26-gene panel (ThyroLead). Patients were classified into RAIR-DTC or non-RAIR groups to determine the differences in clinicopathological and molecular characteristics...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455371/microbiota-in-colorectal-cancer-related-to-liver-metastasis
#3
JOURNAL ARTICLE
Peijun Wei, Weiming Han, Zitong Zhang, Xue Tian, Chen Yang, Qiaoxuan Wang, Weihao Xie, Ying Liu, Yuanhong Gao, Hui Chang
The prevalence of colorectal cancer (CRC) is increasing annually and metastasis is the principal cause of death in patients with CRC, with the liver being the most frequently affected site. Many studies have shown a strong interplay between the gut flora, particularly Fusobacterium nucleatum ( F. nucleatum ), Escherichia coli , and Bacteroides fragilis , and the development of gut tumors. Some strains can induce gut inflammation and produce toxins that directly harm gut epithelial cells, ultimately accelerating the onset and progression of CRC...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455370/plant-based-dietary-patterns-and-risk-of-esophageal-cancer-a-prospective-cohort-study-spanning-17-years
#4
JOURNAL ARTICLE
Xiaorui Zhang, Feifan He, Jiayue Li, Ru Chen, Xinqing Li, Li Li, Fen Liu, Shaoming Wang, Wenqiang Wei
OBJECTIVE: Plant-based diets have multiple health benefits for cancers; however, little is known about the association between plant-based dietary patterns and esophageal cancer (EC).This study presents an investigation of the prospective associations among three predefined indices of plant-based dietary patterns and the risk of EC. METHODS: We performed endoscopic screening for 15,709 participants aged 40-69 years from two high-risk areas of China from January 2005 to December 2009 and followed the cohort until December 31, 2022...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455369/sequential-neoadjuvant-chemotherapy-using-pegylated-liposomal-doxorubicin-and-cyclophosphamide-followed-by-taxanes-with-complete-trastuzumab-and-pertuzumab-treatment-for-her2-positive-breast-cancer-a-phase-ii-single-arm-study
#5
JOURNAL ARTICLE
Yaping Yang, Liang Jin, Yudong Li, Nanyan Rao, Chang Gong, Shunrong Li, Jiannan Wu, Jinghua Zhao, Linxiaoxiao Ding, Fengxia Gan, Jun Zhang, Ruifa Feng, Zhenzhen Liu, Qiang Liu
OBJECTIVE: Despite cardiotoxicity overlap, the trastuzumab/pertuzumab and anthracycline combination remains crucial due to significant benefits. Pegylated liposomal doxorubicin (PLD), a less cardiotoxic anthracycline, was evaluated for efficacy and cardiac safety when combined with cyclophosphamide and followed by taxanes with trastuzumab/pertuzumab in human epidermal growth factor receptor-2 (HER2)-positive early breast cancer (BC). METHODS: In this multicenter, phase II study, patients with confirmed HER2-positive early BC received four cycles of PLD (30-35 mg/m2 ) and cyclophosphamide (600 mg/m2 ), followed by four cycles of taxanes (docetaxel, 90-100 mg/m2 or nab-paclitaxel, 260 mg/m2 ), concomitant with eight cycles of trastuzumab (8 mg/kg loading dose, then 6 mg/kg) and pertuzumab (840 mg loading dose, then 420 mg) every 3 weeks...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455368/genomic-characterization-of-peritoneal-lavage-cytology-positive-gastric-cancer
#6
JOURNAL ARTICLE
Zhouqiao Wu, Tingfei Gu, Changxian Xiong, Jinyao Shi, Jingpu Wang, Ting Guo, Xiaofang Xing, Fei Pang, Ning He, Rulin Miao, Fei Shan, Yuan Zhou, Ziyu Li, Jiafu Ji
OBJECTIVE: Positive peritoneal lavege cytology (CY1) gastric cancer is featured by dismal prognosis, with high risks of peritoneal metastasis. However, there is a lack of evidence on pathogenic mechanism and signature of CY1 and there is a continuous debate on CY1 therapy. Therefore, exploring the mechanism of CY1 is crucial for treatment strategies and targets for CY1 gastric cancer. METHODS: In order to figure out specific driver genes and marker genes of CY1 gastric cancer, and ultimately offer clues for potential marker and risk assessment of CY1, 17 cytology-positive gastric cancer patients and 31 matched cytology-negative gastric cancer patients were enrolled in this study...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455367/molecular-features-of-gastroenteropancreatic-neuroendocrine-carcinoma-a-comparative-analysis-with-lung-neuroendocrine-carcinoma-and-digestive-adenocarcinomas
#7
JOURNAL ARTICLE
Jianwei Zhang, Hanxiao Chen, Junli Zhang, Sha Wang, Yanfang Guan, Wenguang Gu, Jie Li, Xiaotian Zhang, Jian Li, Xicheng Wang, Zhihao Lu, Jun Zhou, Zhi Peng, Yu Sun, Yang Shao, Lin Shen, Minglei Zhuo, Ming Lu
OBJECTIVE: There is an ongoing debate about whether the management of gastroenteropancreatic (GEP) neuroendocrine carcinoma (NEC) should follow the guidelines of small-cell lung cancer (SCLC). We aim to identify the genetic differences of GEPNEC and its counterpart. METHODS: We recruited GEPNEC patients as the main cohort, with lung NEC and digestive adenocarcinomas as comparative cohorts. All patients undergone next-generation sequencing (NGS). Different gene alterations were compared and analyzed between GEPNEC and lung NEC (LNEC), GEPNEC and adenocarcinoma to yield the remarkable genes...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455366/a-phase-i-study-of-hemay022-an-irreversible-dual-egfr-her2-tyrosine-kinase-inhibitor-in-chinese-patients-with-her2-positive-advanced-breast-cancer
#8
JOURNAL ARTICLE
Pin Zhang, Lin Wang, Yueying Zhen, Zhihong Wang, Hesheng Zhang, Richard Jones, Binghe Xu
OBJECTIVE: Hemay022 is a novel small-molecule and an irreversible tyrosine kinase inhibitor with the target of epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor 2 (HER2), which demonstrated anti-tumor activity in preclinical studies. This first-in-human study evaluated the safety, pharmacokinetics, tolerability and preliminary anti-tumor activity of Hemay022 in HER2-positive advanced breast cancer patients. METHODS: Heavily pretreated patients with HER2-positive advanced breast cancer were assigned to eight dose cohorts in a 3+3 dose-escalation pattern at doses of 50-600 mg QD and 300 mg BID...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38455365/clinicopathological-significance-and-immunotherapeutic-outcome-of-claudin-18-2-expression-in-advanced-gastric-cancer-a-retrospective-study
#9
JOURNAL ARTICLE
Changsong Qi, Xiaoyi Chong, Ting Zhou, Mingyang Ma, Jifang Gong, Miao Zhang, Jian Li, Jun Xiao, Xiaohui Peng, Zhen Liu, Zonghai Li, Lin Shen, Xiaotian Zhang
OBJECTIVE: Immunotherapeutic outcomes and clinical characteristics of claudin 18 isoform 2 positive (CLDN18.2-positive) gastric cancer (GC) vary in different clinical studies, making it difficult to optimize anti-CLDN18.2 therapy. We conducted a retrospective analysis to explore the association of CLDN18.2 expression with clinicopathological characteristics and immunotherapeutic outcomes in GC. METHODS: A total of 536 advanced GC patients from 2019 to 2021 in the CT041-CG4006 and CT041-ST-01 clinical trials were included in the analysis...
February 29, 2024: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204451/challenge-and-future-of-cancer-screening-in-china-insights-from-esophageal-cancer-screening-practice
#10
JOURNAL ARTICLE
Zhonghu He, Yang Ke
Cancer stands as a prominent public health concern in China, with elusive intervention targets due to unidentified high-risk causal factors for most cancers. Consequently, emphasis has shifted towards screening, diagnosing, and treating early cancer cases within the general population. However, China faces considerable obstacles in its cancer prevention and control efforts, attributing to the complexity and heterogeneity of the occurrence, progression, and prognosis of malignant tumors across populations, time, and regions...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204450/gastric-cancer-surgery-in-south-korea-past-present-and-future
#11
JOURNAL ARTICLE
Sung Gon Kim, Sang Eok Lee, Bang Wool Eom, Hong Man Yoon, Young-Woo Kim, Keun Won Ryu
Gastric cancer remains a significant global health concern and its surgical management approaches have undergone significant changes in South Korea and worldwide. Subtotal or total gastrectomy with D2 lymph node dissection is well established as a standard surgical procedure for gastric cancer. With the active implementation of cancer screening in South Korea, the proportion of early gastric cancer cases has significantly increased over the past few decades, leading to a steady increase in the survival rate among patients...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204449/breast-cancer-epidemiology-risk-factors-and-screening
#12
JOURNAL ARTICLE
Hangcheng Xu, Binghe Xu
Breast cancer is a global health concern with a significant impact on the well-being of women. Worldwide, the past several decades have witnessed changes in the incidence and mortality of breast cancer. Additionally, epidemiological data reveal distinct geographic and demographic disparities globally. A range of modifiable and non-modifiable risk factors are established as being associated with an increased risk of developing breast cancer. This review discusses genetic, hormonal, behavioral, environmental, and breast-related risk factors...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204448/epidemiology-and-early-screening-strategies-for-colorectal-cancer-in-china
#13
JOURNAL ARTICLE
Yong Yang, Zhaoya Gao, An Huang, Jingyi Shi, Zhuang Sun, Haopeng Hong, Jin Gu
China ranks the first worldwide in the number of new colorectal cancer (CRC) cases and CRC-related deaths. The increasing incidence of early-onset CRC in recent years highlights the challenges related to CRC screening and prevention. High-quality colonoscopy is the universally used gold standard for CRC screening. Risk assessment combined with a two-step screening strategy based on colonoscopy and non-invasive examinations was proven to be highly effective. However, systematic use of well-established risk factors associated with CRC, beyond age, could better identify those who might harbor advanced colorectal neoplasia, improve the diagnostic yield of current screening modalities, and optimize the selection of individuals who might benefit most from preventive strategies...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204447/double-tract-reconstruction-is-superior-to-esophagogastrostomy-in-controlling-reflux-esophagitis-and-enhancing-quality-of-life-after-proximal-gastrectomy-results-from-a-prospective-randomized-controlled-clinical-trial-in-china
#14
JOURNAL ARTICLE
Yinan Zhang, Hongtao Zhang, Yan Yan, Ke Ji, Ziyu Jia, Heli Yang, Biao Fan, Anqiang Wang, Xiaojiang Wu, Ji Zhang, Jiafu Ji, Xin Ji, Zhaode Bu
OBJECTIVE: The aim of this study was to prospectively compare double-tract reconstruction (DTR) and esophagogastrostomy (EG) after proximal gastrectomy (PG) regarding the incidence of reflux esophagitis, quality of life (QOL), nutritional status and surgical safety. METHODS: This study was a randomized controlled trial. Patients eligible for PG were enrolled and randomly assigned to the EG group and DTR group. The characteristics of patients, parameters for surgical safety, incidence of reflux esophagitis, nutrition status and QOL were collected and compared between the two groups...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204446/a-multicenter-study-on-efficacy-of-dual-target-neoadjuvant-therapy-for-her2-positive-breast-cancer-and-a-consistent-analysis-of-efficacy-evaluation-of-neoadjuvant-therapy-by-miller-payne-and-rcb-pathological-evaluation-systems-csbrs-026
#15
JOURNAL ARTICLE
Hongyu Xiang, Ling Xin, Jingming Ye, Ling Xu, Hong Zhang, Shuang Zhang, Yinhua Liu
OBJECTIVE: The aim of this study was to investigate the factors influencing pathological complete response (pCR) rate in early breast cancer patients receiving neoadjuvant dual-target [trastuzumab (H) + pertuzumab (P)] therapy combined with chemotherapy. Additionally, the consistency of the Miller-Payne and residual cancer burden (RCB) systems in evaluating the efficacy of neoadjuvant therapy for early human epidermal growth factor receptor-2 (HER2)+ breast cancer was analyzed. METHODS: The clinicopathological data of female patients with early-stage HER2+ breast cancer who received dual-target neoadjuvant therapy at 26 hospitals of the Chinese Society of Breast Surgery (CSBrS) from March 2019 to December 2021 were collected...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204445/health-economic-evaluation-on-population-based-helicobacter-pylori-eradication-and-endoscopic-screening-for-gastric-cancer-prevention
#16
JOURNAL ARTICLE
Zhiqiang Hu, Zongchao Liu, Wenqing Li, Weicheng You, Kaifeng Pan
Gastric cancer is a global public health burden, nearly one million new cases are diagnosed per year worldwide, of which 44% of cases occur in China. The prognosis of gastric cancer varies remarkably by the stage of cancer, and most of the patients in China are diagnosed at advanced stages, resulting in poor prognoses. Effective strategies to reduce the burden of gastric cancer include primary prevention through testing and treatment of Helicobacter pylori ( H. pylori ) and secondary prevention by screening and early detection...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204444/preface-to-special-issue-cancer-epidemiology-risk-factors-and-screening
#17
JOURNAL ARTICLE
Binghe Xu, Hangcheng Xu
No abstract text is available yet for this article.
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204443/estimation-of-economic-burden-throughout-course-of-cervical-squamous-intraepithelial-lesion-and-cervical-cancer-in-china-a-nationwide-multicenter-cross-sectional-study
#18
JOURNAL ARTICLE
Hao Chen, Xuelian Zhao, Shangying Hu, Tingting You, Changfa Xia, Meng Gao, Mingjie Dong, Youlin Qiao, Fanghui Zhao
OBJECTIVE: Cervical squamous intraepithelial lesion (SIL) and cervical cancer are major threats to females' health and life in China, and we aimed to estimate the economic burden associated with their diagnosis and treatment. METHODS: A nationwide multicenter, cross-sectional, hospital-based survey was conducted in 26 qualified hospitals across seven administrative regions of China. We investigated females who had been pathologically diagnosed with SIL and cervical cancer, and included five disease courses ("diagnosis", "initial treatment", "chemoradiotherapy", "follow-up" and "recurrence/progression/metastasis") to estimate the total costs...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204442/exploring-ideal-operative-time-for-best-outcomes-in-gastric-cancer-surgery-a-multi-institutional-study-based-on-klass-07-database
#19
JOURNAL ARTICLE
Shin-Hoo Park, Ye-Rim Shin, Hoon Hur, Chang Min Lee, Jae Seok Min, Seung Wan Ryu, Hyun Dong Chae, Oh Jeong, Chang-In Choi, Kyo-Young Song, Ho Goon Kim, Ye Seob Jee, Kwang Hee Kim, Jeong Goo Kim, Kyung Sook Yang, Hua Huang, Sungsoo Park
OBJECTIVE: While a rushed operation can omit essential procedures, prolonged operative time results in higher morbidity. Nevertheless, the optimal operative time range remains uncertain. This study aimed to estimate the ideal operative time range and evaluate its applicability in laparoscopic cancer surgery. METHODS: A prospectively collected multicenter database of 397 patients who underwent laparoscopic distal gastrectomy were retrospectively reviewed. The ideal operative time range was statistically calculated by separately analyzing the operative time of uneventful surgeries...
December 30, 2023: Chinese Journal of Cancer Research
https://read.qxmd.com/read/38204441/lung-cancer-burden-and-trends-from-2000-to-2018-in-china-comparison-between-china-and-the-united-states
#20
JOURNAL ARTICLE
Yi Teng, Changfa Xia, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Qianru Li, Nuopei Tan, Jiachen Wang, Wanqing Chen
OBJECTIVE: This study aims to provide an analysis of the current status and trends of lung cancer incidence and mortality rates in China, comparing trends with those in the United States (U.S.). METHODS: Data on lung cancer incidence and mortality rates spanning 2000 to 2018 were extracted from the China Cancer Registry Annual Report and the Surveillance, Epidemiology, and End Results database for China and the U.S., respectively. Crude incidence and mortality rates were calculated by sex and age, with age-standardized incidence rates (ASIR) and mortality rates (ASMR) calculated using the Segi-Doll world standard population...
December 30, 2023: Chinese Journal of Cancer Research
journal
journal
31474
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.